The US approves a type of electronic cigarette: why this decision?

The United States Food and Drug Administration (FDA) authorized this Wednesday the sale of a brand of electronic cigarettes RJ Reynolds firm for understanding that they can help smokers quit.

SIGHT: COVID-19: Booster Vaccine Combination Raises Antibodies, Preliminary Study Reveals

Electronic cigarettes for vaping have been marketed and popularized in the United States for more than a decade without government regulation. Now, in compliance with a court ruling, the FDA has given its approval after studying this product.

The agency authorizes the sale of the Vuse brand of electronic cigarettes because it understands that the benefits of this device for adults who want to abandon the traditional cigarette outweigh the risks of addiction among teens.

SIGHT: CureVac abandons its initial project and focuses on another: What is a second-generation vaccine?

According to the FDA, Vuses help smokers cut down on tobacco use or even quit.

The FDA study concludes that Vuse reduces exposure to toxic chemicals in conventional cigarettes, agency director Mitch Zeller said in a statement.

SIGHT: Cuba tests in Italy the efficacy of its vaccine against COVID-19 Soberana Plus

The Vuse brand offers cigarettes that have the flavor of tobacco, unlike many other brands that offer sweet or fruit flavors and that have become extremely popular with minors who, by law, cannot buy tobacco products.

The FDA and the Centers for Disease Control and Prevention (CDC) released a study last month in which they estimate that more than 2 million schoolchildren have used e-cigarettes so far this year, and 80% of them consumed products with artificial flavors.

The Vuse Solo, which went on sale in 2013, consist of a rechargeable metal device in the shape of a conventional cigarette.

The FDA rejected another ten requests from RJ Reynolds for authorization of products with other flavors, and continues to study a request from that firm for the sale of a formula that It contains nicotine and has a mint flavor.

The price of the shares of British American Tobacco – of which RJ Reynolds is a subsidiary – and of other manufacturers of electronic cigarettes rose after the FDA issued its first authorization for the sale of these types of products.



  • Cuba tests in Italy the efficacy of its vaccine against COVID-19 Soberana Plus
  • Hospital corridors may have higher viral loads than COVID-19 patient rooms
  • EMA ends CureVac vaccine evaluation after trial cancellation
  • COVID-19 | Russia says its Sputnik Light vaccine is 70% effective against Delta variant
  • “Doctors treated my mother like a guinea pig”: scandal in Brazil over misuse of drugs against COVID-19
  • COVID-19 | Pfizer will test the “immune response” to its vaccine in an entire Brazilian city
  • AstraZeneca vaccine: Peruvian volunteers will be followed for two years
  • The WHO officially defines persistent COVID-19 as a disease: what symptoms does it present?
  • CureVac Cancels Initial COVID-19 Vaccine Project
  • Merck Pill Treatment May Be New Weapon Against COVID-19, WHO Says
  • Merck Pill Treatment May Be New Weapon Against COVID-19, WHO Says
  • COVID-19 | Why do WHO experts say that the Sinopharm vaccine requires three doses?
  • Pfizer and AstraZeneca Vaccines Reduce Risk of Severe COVID-19 by 90%, Study Confirms
  • AstraZeneca Experimental Drug Reduces Severe COVID-19 Cases or Death by 67%
  • Molnupiravir | What You Should Know About MSD’s COVID-19 Pill
  • Ivermectin: How Fake Science Invented a “Miracle” Drug Against COVID-19
  • Third dose reduces the risk of severe illness from COVID-19 by 96%, according to Chilean study
  • What to answer to those who still doubt whether to get vaccinated against COVID-19

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);;js.src=p+’://’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

Leave a Reply